GB Sciences, Inc. (GBLX)
0.0003
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
GB Sciences Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -5.88M |
| September 30, 2024 | -5.780M |
| June 30, 2024 | -5.589M |
| March 31, 2024 | -5.314M |
| December 31, 2023 | -4.847M |
| September 30, 2023 | -4.693M |
| June 30, 2023 | -4.680M |
| March 31, 2023 | -4.407M |
| December 31, 2022 | -1.612M |
| September 30, 2022 | -1.193M |
| June 30, 2022 | -2.166M |
| March 31, 2022 | -1.783M |
| December 31, 2021 | 1.803M |
| September 30, 2021 | -2.538M |
| June 30, 2021 | -2.030M |
| March 31, 2021 | -1.474M |
| December 31, 2020 | -2.496M |
| September 30, 2020 | -2.350M |
| June 30, 2020 | -1.649M |
| March 31, 2020 | -0.0885M |
| December 31, 2019 | 8.302M |
| September 30, 2019 | 5.288M |
| June 30, 2019 | 6.887M |
| March 31, 2019 | 8.300M |
| December 31, 2018 | 10.33M |
| Date | Value |
|---|---|
| September 30, 2018 | 12.88M |
| June 30, 2018 | 13.39M |
| March 31, 2018 | 12.75M |
| December 31, 2017 | 8.476M |
| September 30, 2017 | 7.535M |
| June 30, 2017 | 7.316M |
| March 31, 2017 | 8.327M |
| December 31, 2016 | 3.584M |
| September 30, 2016 | 2.073M |
| June 30, 2016 | -0.6159M |
| March 31, 2016 | -1.896M |
| December 31, 2015 | -1.081M |
| September 30, 2015 | -0.4015M |
| June 30, 2015 | -1.336M |
| March 31, 2015 | 0.4973M |
| December 31, 2014 | 1.148M |
| September 30, 2014 | 2.018M |
| June 30, 2014 | 2.696M |
| March 31, 2014 | -1.013M |
| December 31, 2013 | -1.141M |
| September 30, 2013 | -0.9579M |
| June 30, 2013 | -1.232M |
| March 31, 2013 | -1.190M |
| December 31, 2012 | -0.8324M |
| September 30, 2012 | -0.9223M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
| Definium Therapeutics, Inc. | 918.68M |